Diamyd Medical exhibits at the 51th EASD Annual Meeting in Stockholm, Sweden on 15-18 September 2015. EASD is the biggest annual diabetes conference in Europe and brings about 17,000 people from scientific, medical and research disciplines as well as industry in the field of diabetes.

Erika Hillborg, Senior Director of Clinical Development, Diamyd Medical and Dr. Helena Elding Larsson, Lund University, lead investigator and sponsor of the placebo controlled studies DiAPREV-IT 1 and DiAPREV-IT 2, where the diabetes vaccine Diamyd^® is given to children at high risk of developing type 1 diabetes with the aim of preventing or delaying the disease.

Read more about the event here